Dr. Hinckley used Igenomix’s endometrial receptivity analysis to time Tara’s embryo transfer.
A recent patient story published on RSC’s website outlined Tara and Nick’s infertility treatment with Dr. Mary Hinckley. Integral to the birth of Tara and Nick’s daughter was a special test developed by the Igenomix biotechnology company called the endometrial receptivity analysis (ERA) that aids in the timing of embryo transfers during certain in vitro fertilization (IVF) cycles.
The ERA analyzes the cellular genetics of the endometrium (the lining of the uterus). It is particularly useful in cases where previous embryo transfers have failed, as it allows the physician to pinpoint the optimal window of receptivity for embryo transfer.